Foreign exchange trading center: terminate the products related to the old benchmark interest rate and support the products related to the new international benchmark interest rate
According to the foreign exchange trading center, CFETS foreign exchange trading system has made relevant arrangements for the termination of some London Interbank Offered Rate (LIBOR) interest rates. The announcement said that it supports products linked to the new international benchmark interest rate. From April 20, 2020, foreign exchange trading system, instant messaging tool ideal and other systems have supported currency swaps and foreign currency interest rate swaps linked to new international benchmark interest rates such as dollar guaranteed overnight financing interest rate (sofr), sterling overnight index average (Sonia), Euro short-term interest rate (estr), Tokyo overnight average interest rate (tonar); Since August 23, 2021, the foreign exchange trading system has supported floating rate foreign currency lending linked to sofr.
This text is a result of machine translation.
Related companies：
In-depth
Healthcare
China's First Oral COVID-19 Antiviral Medicine in Dispute
An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.
Aug 08, 2022 09:00 AM
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
Jan 05, 2023 07:33 PM
Nov 16, 2022 05:19 PM
Healthcare, Financials
Fosun Pharma Net Profit down 45% in Q1 2022 as Value of Financial Assets Slumps
Founded in 1994, Shanghai Fosun Pharma is a global pharmaceutical and health group rooted in China and driven by innovation. Its businesses include pharmaceuticals, medical devices and diagnosis, medical and health services. The group covers the pharmaceutical field through participation in Sinopharm Holdings.
Apr 27, 2022 10:55 PM
Briefing Feb 17, 2022 10:08 AM
Yingsi intelligence and Fosun Pharmaceutical reached the first milestone of strategic cooperation: nomination and targeting cd47-sirp α Small molecule compounds of signal pathway
Briefing Jan 24, 2022 02:39 PM
The main force continued to increase its position in lithium battery stocks in the late trading, and sold off banks and pharmaceutical stocks
See more
Read next
Insight
In-depth
Insight
In-depth